Waltham, Massachusetts Clinical Trials

A listing of Waltham, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 108 clinical trials
Treatment of Pregnant Women With OUD

The investigators are testing two models of support for pregnant women with an opioid use disorder (OUD)

Beth Israel Deaconess Medical Center
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +11 other locations
Study to Assess AFM24 in Advanced Solid Cancers

AFM24-101 is a first in human Phase 1/2a open-label, non-randomized, multi-center, multiple ascending dose escalation/expansion study evaluating AFM24 as monotherapy in patients with advanced solid malignancies whose disease has progressed after treatment with previous anticancer therapies. There will be two parts to this study: a dose escalation phase (1) and …

cancer treatment
kidney cancer
glioblastoma multiforme
colorectal cancer
measurable disease
Dana Faber Cancer Institute
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
Efficacy of Near-Infrared Vein Imaging for Difficult IV Placement

The objective of this project is to define the effectiveness and therefore the role of NIR vein finders in adult patients with difficult peripheral venous access. The specific objective of the proposed randomized controlled trial is to test the clinical success rate of placing peripheral venous catheters in 'difficult' access …

Lahey Clinic
 (6.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

This study will assess the safety, efficacy, and pharmacokinetics of DS-6157a in participants with advanced gastrointestinal stromal tumors (GIST).

metastasis
tyrosine
gilbert's syndrome
measurable disease
chemotherapeutic agent
Dana Farber Cancer Institute
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate …

covid-19
blood test
Massachusetts General Hospital
 (9.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +10 other locations
Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19)

The objectives of this study are to evaluate the safety, tolerability and efficacy of AT-527 in older subjects (ages 45-80 years) with moderate COVID-19 and risk factors for poor outcomes (such as obesity (BMI>30), hypertension, diabetes or asthma). Eligible subjects will be randomized to blinded AT-527 (nucleotide analog) tablets or …

asthma
acute respiratory syndrome (sars)
coronavirus infection
SARS
covid-19
Atea Study Site
 (8.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

This is a Phase 1 study of JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway mutations, including mutations that cause MAPK pathway hyperactivation.

metastasis
gene fusion
gilbert's syndrome
metastatic melanoma
measurable disease
Massachusetts General Hospital Cancer Center
 (9.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
A Study of LY3819253 (LY-CoV555) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 works against the virus that causes COVID-19. LY3819253 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus …

cardiovascular disease
sickle cell disease
heart disease
intermittent positive pressure ventilation
respiratory disorder
Massachusetts General Hospital
 (9.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +61 other locations
Lung Irradiation for COVID-19 Pneumonia

In this research study the investigators want to learn more about the potential benefit of radiation to the lung to improve the health of patients who are hospitalized with Coronavirus-19 (COVID-19) due to infection with a virus called SARS-CoV-2. This infection causes inflammation of the lung, which can make it …

lopinavir/ritonavir
low dose radiation therapy
acute respiratory syndrome (sars)
antiviral drugs
favipiravir
Brigham and Women's Hospital
 (8.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function

This exploratory, open-label clinical study aims to explore the physiologic effects of KB109, a novel glycan, on adult patients with COVID-19 illness on gut microbiota structure and function in the outpatient setting.

Massachusetts General Hospital
 (9.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location